Short description
Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design.
Description
Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design. Its platform, LIME, is transforming the drug discovery process. The company combines the latest tools in AI technology with plethoras of small molecular data to discover new candidates and medicines for targeted diseases.
Total funding
$$43214321
Sign in for full access
Location
Daphne, Alabama, United States, North America
Founded on
January 1, 2020
Non-profit?
Yes
Acquired?
Yes
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Founders
Rick Fine, Will Spagnoli